SRTD Biotech: Funding, Investors & Team (Nov 2026)
It is our mission to open a new chapter in treating diseases and to deliver so called selectively expressed RNAs (seRNAs) to patients. We have an ambitious pipeline that targets indications of highest medical need. Many devastating diseases cannot be effectively treated. Even if therapies exist, often they don’t specifically target the diseased area, leading to a high risk of severe side effects. To overcome this inherent problem, we have developed seRNA as a new RNA-based therapy approach.
SRTD Biotech has raised $35.1M across 2 funding rounds on record, the most recent a Seed of $35.1M announced in Nov 2026.
That round is above the $8.9M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
SRTD Biotech Company Profile and Key Stats
Latest funding round on record: Nov 2026.
SRTD Biotech Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
SRTD Biotech announced a Seed in Nov 2024; the amount was not disclosed.
2 years later, a Seed of $35.1M was announced in Nov 2026.
SRTD Biotech Investors
6 investors are recorded in total; the 5 named above are those the record identifies.
SRTD Biotech Founders and Leadership Team
Contact details for the SRTD Biotech team: 2 of 2 have an email address on file, 2 have a LinkedIn profile.
Start 14-day free trial →SRTD Biotech Funding Compared to Other Biotechnology Startups
SRTD Biotech's latest round of $35.1M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like SRTD Biotech in Biotechnology and Jülich
Companies Similar to SRTD Biotech
Cellbox Solutions is a recently established technology firm that specializes in creative logistics solutions…
Artcline is a biotech company that creates diagnostic and therapeutic techniques for critical care medicine.
Computomics applies AI to bioinformatics data to enable rapid understanding of genomics and drive advanced…
smartbax develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug…
Pacifico Biolabs offers fermentation biotechnology for development, production and distribution of…
NanoStruct is a biotechnology company that develops nanostructured sensor chips to identify bacteria and…
Tacalyx, a company originating from Max-Planck-Institute of Colloids and Interfaces in Potsdam, Germany, is…
Primogene is a biotechnology company that provides ingredient development, bioprocess manufacturing, and…
Mbiomics is a company in the field of biotechnology.
At EVANIUM, we make plant compounds like polyphenols and flavonoids more effective by improving their…
SRTD Biotech Funding FAQs
What does SRTD Biotech do?
It is our mission to open a new chapter in treating diseases and to deliver so called selectively expressed RNAs (seRNAs) to patients. We have an ambitious pipeline that targets indications of highest medical need. Many devastating diseases cannot be effectively treated. Even if therapies exist, often they don’t specifically target the diseased area, leading to a high risk of severe side effects. To overcome this inherent problem, we have developed seRNA as a new RNA-based therapy approach.
How much funding has SRTD Biotech raised?
SRTD Biotech has raised $35.1M across 2 rounds on record. The most recent is a Seed of $35.1M announced in Nov 2026.
When did SRTD Biotech last raise funding?
SRTD Biotech's most recent funding round on record is a Seed of $35.1M, announced in Nov 2026.
Who has invested in SRTD Biotech?
Investors on record for SRTD Biotech include HTGF (High-Tech Gruenderfonds), Eli Lilly, NRW.BANK, Mérieux Equity Partners, Boehringer Ingelheim Venture Fund. FundedIQ records 6 investors in total.
Who founded SRTD Biotech?
FundedIQ lists Bernd Hoffmann (Founder) at SRTD Biotech.
Who is the CEO of SRTD Biotech?
Matthias Alder is listed as Chief Executive Officer at SRTD Biotech.
Where is SRTD Biotech headquartered?
SRTD Biotech is based in Jülich, Nordrhein-Westfalen, Germany.
How many employees does SRTD Biotech have?
SRTD Biotech is in the 11-50 employee band.
How does SRTD Biotech's funding compare to other Biotechnology startups?
SRTD Biotech's latest round of $35.1M is above the $8.9M median round size for Biotechnology companies on FundedIQ across 4,188 tracked companies over the last two years.
About FundedIQ's SRTD Biotech Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for SRTD Biotech is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.